<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2023.134014</article-id><article-id pub-id-type="publisher-id">OJGas-124243</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Helicobacter Pylori Infection: Epidemiological, Clinical and Endoscopic Aspects in Brazzaville
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bienvenu</surname><given-names>H. Atipo-Ibara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anicet</surname><given-names>Boumba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lucie</surname><given-names>C. Atipo Ibara Ollandzobo Ikobo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Arnaud</surname><given-names>Mongo-Onkouo</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jile</surname><given-names>F. Mimiesse Monamou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ngala</surname><given-names>A. Itoua-Ngaporo</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Donatien</surname><given-names>Moukassa</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Blaise</surname><given-names>I. Atipo Ibara</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Rosaire</surname><given-names>Ibara</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Hugues Dieudonné Loemba Molecular Biology Laboratory, Pointe-Noire, Republic of the Congo</addr-line></aff><aff id="aff3"><addr-line>Pointe-Noire Research Zone, National Institute for Research in Health Sciences (IRSSA), Pointe-Noire, Republic of the Congo</addr-line></aff><aff id="aff5"><addr-line>Department of Anatomical Pathology, Edith Lucie Bongo Odimba General Hospital, Oyo, Republic of the Congo</addr-line></aff><aff id="aff4"><addr-line>Department of Gastroenterology and Internal Medicine, CHU Brazzaville, Brazzaville, Republic of the Congo</addr-line></aff><aff id="aff1"><addr-line>Faculty of Health Sciences, Marien Ngouabi University, Brazzaville, Republic of the Congo</addr-line></aff><pub-date pub-type="epub"><day>12</day><month>04</month><year>2023</year></pub-date><volume>13</volume><issue>04</issue><fpage>131</fpage><lpage>139</lpage><history><date date-type="received"><day>9,</day>	<month>February</month>	<year>2023</year></date><date date-type="rev-recd"><day>10,</day>	<month>April</month>	<year>2023</year>	</date><date date-type="accepted"><day>13,</day>	<month>April</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: 
  <em>Helicobacter pylori</em> infection is a real health problem worldwide. It is the most common chronic bacterial infection in the world, and is particularly prevalent in developing countries. 
  Objective: To determine the frequency of 
  <em>Helicobacter pylori </em>infection and to study the epidemiological, clinical and endoscopic characteristics associated with this infection in Brazzaville. 
  Patients and Methods: This was a descriptive cross-sectional study conducted from January to November 2020, 
  <em>i.e. </em>11 months. This work focused on 100 symptomatic patients over 18 years old referred for upper GI endoscopy. Gastric biopsies for biological study by urease test and molecular study by real time PCR technique were taken. 
  Results: With a mean age of 46.32 &#177; 15.20 years, the frequency of 
  <em>Hp</em> infection was 91%, with a female predominance of 53%. The sex ratio was 0.92. The average age was 46.32 &#177; 15.20 years. Carriage of the infection was more important in households with more than 3 persons, in patients consuming public tap water and in those using both types of sanitary facilities. Endoscopy was indicated for epigastralgia in 93.1% of cases. About 56.14% of the infected patients had normal mucosa versus 12.28% with ulcerated lesions and 22.81% with gastritis. 
  Conclusion: The prevalence of
  <em> Helicobacter pylori</em> infection is significant in Congo, justifying early detection in order to improve management.
 
</p></abstract><kwd-group><kwd>&lt;i&gt;Helicobacter pylori&lt;/i&gt;</kwd><kwd> Carriage</kwd><kwd> Chronic Gastritis</kwd><kwd> Gastric Ulcer</kwd><kwd> Brazzaville</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hp infection is a real human health concern worldwide. It is the most common chronic bacterial infection, particularly in developing countries [<xref ref-type="bibr" rid="scirp.124243-ref1">1</xref>] . However, this prevalence can vary considerably, both between different countries in the world and even within a country, depending on the age and socio-economic conditions of the population [<xref ref-type="bibr" rid="scirp.124243-ref2">2</xref>] . Indeed, more than 50% of the world’s population is thought to be infected and 20% - 90% of people are infected depending on the country, with infection being more common in poor and low socio-economic environments [<xref ref-type="bibr" rid="scirp.124243-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref7">7</xref>] .</p><p>In Africa, several studies conducted from 2005 to 2019, place the prevalence of Hp infection between 60% and 91% [<xref ref-type="bibr" rid="scirp.124243-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref11">11</xref>] . In Congo, several studies have investigated the frequency of Hp infection. Ibara et al. in 2005 reported a frequency of 48.7% in children [<xref ref-type="bibr" rid="scirp.124243-ref12">12</xref>] ; Ontsira Ngoyi et al. in 2015 estimated a frequency of 89% in adults [<xref ref-type="bibr" rid="scirp.124243-ref13">13</xref>] . Ngala Itoua-Ngaporo et al. in 2018 estimated that Hp occurs in up to 79.6% of the population [<xref ref-type="bibr" rid="scirp.124243-ref14">14</xref>] and the most recent by Ontsira Ngoyi et al. in 2019 estimated the prevalence at 75.5% [<xref ref-type="bibr" rid="scirp.124243-ref15">15</xref>] .</p><p>The mode and routes of transmission of Hp infection are known. Infection occurs mainly in childhood, via the oral or faecal-oral route. Factors influencing the incidence and prevalence are age, gender, geographical location, promiscuity, poor hygiene and low socio-economic status [<xref ref-type="bibr" rid="scirp.124243-ref16">16</xref>] .</p><p>Hp infection has been implicated in a wide range of gastric mucosal diseases, such as acute and chronic gastritis, gastric ulcer, gastric cancer [<xref ref-type="bibr" rid="scirp.124243-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref17">17</xref>] .</p><p>The aim of this work is to improve the management of patients infected with Helicobacter pylori by studying the epidemiological, clinical and endoscopic features associated with Hp infection.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>This was a descriptive and cross-sectional study from January to November 2020, a period of 11 months. The study was conducted in the cities of Brazzaville and Pointe-Noire. The upper digestive endoscopy and biopsy samples were taken in three endoscopy centres in the city of Brazzaville, namely the Schnell Foundation Medical and Social Centre, the OCH Gastroenterology Medical Centre, and the Gastroenterology and Internal Medicine Department of the Brazzaville University Hospital. The molecular study was carried out at the Hugues Dieudonn&#233; Loemba (HDL) laboratory of the Fondation Marie Madeleine Gombes (FMMG) in Pointe-Noire. The study population consisted of all patients received for oesogastroduodenal endoscopy (EOGD), regardless of the indication, in one of the exploration centres during the study period. We included any consenting patient over 18 years of age, symptomatic patients and those with histologically confirmed gastric cancer. Patients who had taken a PPI and/or antibiotic in the month prior to endoscopy, patients in whom oesogastroduodenal endoscopy was incomplete and biopsy could not be performed, and patients in whom biopsies were not usable were excluded from the study. Our sample size was estimated at 100 patients. Consecutive sampling of patients meeting the inclusion criteria was performed until the estimated number was reached. The study required the opinion of the Health Sciences Research Ethics Committee (N˚303/ MRSIT/IRSSA/CERSSA).</p><p>The data were collected by the same investigator using a pre-established survey form. The form was used to collect information on the risk factors of contamination, i.e. socio-economic and epidemiological aspects, but also certain habits and lifestyle of the patients that could influence the frequency of Hp infection.</p><p>The digestive symptoms were dyspeptic syndrome, nausea, vomiting, digestive haemorrhage, type and location of abdominal pain. Upper GI endoscopy was performed using FUGINON video endoscopes in the Brazzaville University Hospital and Olympus<sup>&#174;</sup> GIF V2, GIFQ 145 in the other centres, as well as accessory equipment that was carefully disinfected and sterilised before the examination according to SFED recommendations. During the examination, samples were taken with a single-use biopsy forceps from two sites: the antral mucosa and the fundic mucosa. For each site, two biopsy fragments of approximately 0.5 mm in diameter were taken. For each of the two sites, one fragment was taken for urease testing and one fragment for molecular biology. Biopsies for molecular study were cryopreserved, frozen at −32˚C.</p><p>The rapid urease test was performed in the endoscopy room immediately after the examination, using the Pronto Dry New, Cadrex test. This test allowed rapid detection of the bacteria based on its main property, urease production. The test was positive when the indicator (ring) with a yellow base gradually turns from pink to purplish red at room temperature.</p><p>The molecular study was carried out on fresh cryopreserved biopsies using the real-time PCR technique in two consecutive steps: DNA extraction using the “ReliaPrep<sup>TM</sup> gDNA tissue Miniprep system from Promega” and DNA amplification for Hp detection using the “Techne<sup>TM</sup> PrimePRO qPCR DNA detection Kit, H Pylori”.</p></sec><sec id="s3"><title>3. Results</title><p>Of the 100 patients in our study population, 84 patients were positive by urease test and 91 by PCR. Based on our variable of interest, PCR, the overall frequency of Hp infection was 91% (<xref ref-type="table" rid="table1">Table 1</xref>). Our study population was predominantly female, 53% of the women were carriers of the bacteria. The mean age of the patients was 46.32 &#177; 15.20 years with a peak of infection (32.97%) between 40 and 49 years (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Hp infection was higher in patients with an average socio-economic status of 61.54%.</p><p>Regarding household size, the frequency of Hp infection was 86.9% for households with more than 3 persons. Hp infection was found in 59% of patients using tap water, 45% using modern toilets and 42% using latrines (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Out of a total of 100 patients included in our study, 87 patients presented with abdominal pain. Hp was found in 92.5% of the patients with epigastric pain, 65%</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Frequency of infection according to the results of the two Hp tests in the study population</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >VARIABLES</th><th align="center" valign="middle"  colspan="3"  >PCR</th></tr></thead><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >Total</td></tr><tr><td align="center" valign="middle" >Urease positive</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >84</td></tr><tr><td align="center" valign="middle" >Urease negative</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >16</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >91</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>p = 0.01.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of infection by household size and living arrangements</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >VARIABLES</th><th align="center" valign="middle"  colspan="2"  >PCR result</th><th align="center" valign="middle"  rowspan="3"  >p-Value</th></tr></thead><tr><td align="center" valign="middle" >Positive (N = 91)</td><td align="center" valign="middle" >Negative (N = 9)</td></tr><tr><td align="center" valign="middle" >n (%)</td><td align="center" valign="middle" >n (%)</td></tr><tr><td align="center" valign="middle" >Household size</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;3</td><td align="center" valign="middle" >11 (13.1)</td><td align="center" valign="middle" >7 (43.8)</td><td align="center" valign="middle" >0.003</td></tr><tr><td align="center" valign="middle" >3 - 7</td><td align="center" valign="middle" >60 (71.4)</td><td align="center" valign="middle" >8 (50)</td><td align="center" valign="middle" >0.09</td></tr><tr><td align="center" valign="middle" >&gt;7</td><td align="center" valign="middle" >13 (15.5)</td><td align="center" valign="middle" >1 (6.2)</td><td align="center" valign="middle" >0.3</td></tr><tr><td align="center" valign="middle" >Types of sanitary facilities</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Latrines</td><td align="center" valign="middle" >42 (46.15)</td><td align="center" valign="middle" >6 (66.67)</td><td align="center" valign="middle" >0.2</td></tr><tr><td align="center" valign="middle" >Modern</td><td align="center" valign="middle" >45 (49.45)</td><td align="center" valign="middle" >3 (33.33)</td><td align="center" valign="middle" >0.3</td></tr><tr><td align="center" valign="middle" >Both</td><td align="center" valign="middle" >4 (4.40)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" >Modern Water Source</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Public tap</td><td align="center" valign="middle" >59 (64.84)</td><td align="center" valign="middle" >7 (77.78)</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Mineral water</td><td align="center" valign="middle" >24 (26.37)</td><td align="center" valign="middle" >2 (22.22)</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Well</td><td align="center" valign="middle" >3 (3.30)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" >*Other</td><td align="center" valign="middle" >5 (5.49)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.4</td></tr></tbody></table></table-wrap><p>of which was burning (<xref ref-type="table" rid="table3">Table 3</xref>). The frequency of Hp infection was higher in patients with nausea/vomiting followed by dyspeptic disorders, however, 74% of GI bleeding was related to Hp, and 81% of melenas presented by patients were related to Hp. All patients included in the study had undergone upper GI endoscopy. Endoscopy was normal in 70% of the patients, and revealed pathological mucosa in 30% of the patients. Endoscopy was indicated for epigastralgia in 93.1% of cases. It revealed normal mucosa (56.14%), ulcerated lesions (12.28%) and gastritis (22.81%) in infected patients. The bacterium was exclusive in acanthosis (100%) and frosted lesions (100%). This result is shown in <xref ref-type="table" rid="table4">Table 4</xref> &amp; <xref ref-type="table" rid="table5">Table 5</xref>.</p></sec><sec id="s4"><title>4. Discussion</title><p>Considered the only carcinogenic bacterium to date, Hp infection is a major public health concern in developing countries. The aim of this study was to investigate the epidemiological, clinical and endoscopic factors associated with Hp infection.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of infection according to the nature of the pain</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >VARIABLES</th><th align="center" valign="middle"  colspan="2"  >PCR result</th><th align="center" valign="middle"  rowspan="3"  >p-Value</th></tr></thead><tr><td align="center" valign="middle" >Positive (N = 91)</td><td align="center" valign="middle" >Negative (N = 9)</td></tr><tr><td align="center" valign="middle" >n (%)</td><td align="center" valign="middle" >n (%)</td></tr><tr><td align="center" valign="middle" >Location of pain</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Epigastrium</td><td align="center" valign="middle" >74 (92.5)</td><td align="center" valign="middle" >8 (100)</td><td align="center" valign="middle" >0.4</td></tr><tr><td align="center" valign="middle" >Right hypochondrium</td><td align="center" valign="middle" >2 (2.5)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.6</td></tr><tr><td align="center" valign="middle" >Available at</td><td align="center" valign="middle" >4 (5.0)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.5</td></tr><tr><td align="center" valign="middle" >Type of pain</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Burn</td><td align="center" valign="middle" >52 (65)</td><td align="center" valign="middle" >3 (42.86)</td><td align="center" valign="middle" >0.2</td></tr><tr><td align="center" valign="middle" >Cramp</td><td align="center" valign="middle" >25 (31.25)</td><td align="center" valign="middle" >4 (57.14)</td><td align="center" valign="middle" >0.1</td></tr><tr><td align="center" valign="middle" >Vice</td><td align="center" valign="middle" >1 (1.25)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Not specified</td><td align="center" valign="middle" >2 (2.50)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.6</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of infection according to symptoms</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >VARIABLES</th><th align="center" valign="middle"  colspan="2"  >PCR result</th><th align="center" valign="middle"  rowspan="3"  >p-Value</th></tr></thead><tr><td align="center" valign="middle" >Positive (N = 91)</td><td align="center" valign="middle" >Negative (N = 9)</td></tr><tr><td align="center" valign="middle" >n (%)</td><td align="center" valign="middle" >n (%)</td></tr><tr><td align="center" valign="middle" >Digestive symptoms</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Nausea</td><td align="center" valign="middle" >34 (25.19)</td><td align="center" valign="middle" >4 (17.39)</td><td align="center" valign="middle" >0.6</td></tr><tr><td align="center" valign="middle" >Early feeling of fullness</td><td align="center" valign="middle" >29 (21.48)</td><td align="center" valign="middle" >5 (21.75)</td><td align="center" valign="middle" >0.1</td></tr><tr><td align="center" valign="middle" >Feeling of fullness in the stomach</td><td align="center" valign="middle" >22 (16.30)</td><td align="center" valign="middle" >4 (17.39)</td><td align="center" valign="middle" >0.1</td></tr><tr><td align="center" valign="middle" >Vomiting</td><td align="center" valign="middle" >30 (22.22)</td><td align="center" valign="middle" >3 (13.04)</td><td align="center" valign="middle" >0.9</td></tr><tr><td align="center" valign="middle" >Hematemesis</td><td align="center" valign="middle" >7 (5.19)</td><td align="center" valign="middle" >4 (17.39)</td><td align="center" valign="middle" >0.0007</td></tr><tr><td align="center" valign="middle" >M&#233;l&#233;na</td><td align="center" valign="middle" >13 (9.62)</td><td align="center" valign="middle" >3 (13.04)</td><td align="center" valign="middle" >0.1</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of infection according to endoscopy findings</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >VARIABLES</th><th align="center" valign="middle"  colspan="2"  >PCR result</th><th align="center" valign="middle"  rowspan="3"  >p-Value</th></tr></thead><tr><td align="center" valign="middle" >Positive (N = 91)</td><td align="center" valign="middle" >Negative (N = 9)</td></tr><tr><td align="center" valign="middle" >n (%)</td><td align="center" valign="middle" >n (%)</td></tr><tr><td align="center" valign="middle" >Endoscopic aspects of patients</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal mucosa</td><td align="center" valign="middle" >64 (56.14)</td><td align="center" valign="middle" >6 (37.5)</td><td align="center" valign="middle" >0.8</td></tr><tr><td align="center" valign="middle" >Ulcerated lesion</td><td align="center" valign="middle" >14 (12.28)</td><td align="center" valign="middle" >3 (18.75)</td><td align="center" valign="middle" >0.1</td></tr><tr><td align="center" valign="middle" >Budding lesion</td><td align="center" valign="middle" >3 (2.63)</td><td align="center" valign="middle" >2 (12.5)</td><td align="center" valign="middle" >0.01</td></tr><tr><td align="center" valign="middle" >Frosted lesion</td><td align="center" valign="middle" >1 (0.88)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Erosive aspect</td><td align="center" valign="middle" >12 (10.53)</td><td align="center" valign="middle" >1 (6.25)</td><td align="center" valign="middle" >0.8</td></tr><tr><td align="center" valign="middle" >Congestive aspect</td><td align="center" valign="middle" >14 (12.28)</td><td align="center" valign="middle" >1 (6.25)</td><td align="center" valign="middle" >0.7</td></tr><tr><td align="center" valign="middle" >Infiltrated appearance</td><td align="center" valign="middle" >1 (0.88)</td><td align="center" valign="middle" >2 (12.5)</td><td align="center" valign="middle" >0.0003</td></tr><tr><td align="center" valign="middle" >Acanthosis lesion</td><td align="center" valign="middle" >2 (1.75)</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.6</td></tr><tr><td align="center" valign="middle" >*Other</td><td align="center" valign="middle" >3 (2.63)</td><td align="center" valign="middle" >1 (6.25)</td><td align="center" valign="middle" >0.2</td></tr></tbody></table></table-wrap><p>Two identification techniques (urease and PCR) were used to assess the carriage of Helicobacter pylori infection in the study population. Of the 100 patients in our study population, 84 were urease positive and 91 were PCR positive. Some patients (11) were urease negative and PCR positive. The high frequency of Helicobacter pylori by PCR demonstrates the improved sensitivity of PCR and the limitation of the urease technique which can only detect secreting strains. Furthermore, there was a statistically significant difference between these two tests (p = 0.01). The variable of interest being the PCR, the frequency of Helicobacter pylori infection was 91%. This frequency was higher in women (53%). Aguemon et al. in Benin and Bommelaer et al. in France also reported a female predominance of infection [<xref ref-type="bibr" rid="scirp.124243-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref18">18</xref>] , while ATTAF N et al. in Morocco and Ould Bouh et al. in Mauritania reported a male predominance [<xref ref-type="bibr" rid="scirp.124243-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref20">20</xref>] .</p><p>All age groups were affected, with a higher frequency in younger patients, particularly those under 50 years of age, with a peak between 40 and 49 years of age (32.97%). No significant difference was found between age and Hp infection (p = 0.567). This result is similar to those reported by some studies in Africa, which found no significant difference between the presence of Hp and age [<xref ref-type="bibr" rid="scirp.124243-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.124243-ref21">21</xref>] .</p><p>Hp infection was higher in patients with an average socioeconomic status of 61.54%. This result is similar to that obtained by Bagny et al. in Togo who obtained a higher frequency of Hp infection in the middle socio-economic class in 63.3% of cases [<xref ref-type="bibr" rid="scirp.124243-ref22">22</xref>] . On the other hand, Ankouane et al. in Cameroon and Ilboudo et al. in Burkina Faso obtained a frequency of 73.9% and 77.9% respectively in patients with a low socio-economic level [<xref ref-type="bibr" rid="scirp.124243-ref21">21</xref>] .</p><p>Regarding patients’ lifestyle, our results showed that regardless of household size or lifestyle, these factors were not directly related to Hp infection. However, a higher tendency of infection was observed in patients using tap water (59%) compared to those using other water sources. This result can be explained by the fact that more than half of the Congolese population uses this water source. This result can be explained by the fact that more than half of the Congolese population uses this source of water, as reported by Aguemon et al. in Benin [<xref ref-type="bibr" rid="scirp.124243-ref8">8</xref>] who found an association between Hp infection and latrine use.</p><p>Of the 43.86% of Hp-positive patients with abnormal endoscopy, a statistically significant difference was observed with patients with infiltrated (p = 0.0003) and budding (p = 0.01) lesions. Carriage of Hp infection was exclusive in acanthosis (100%) and frosted lesions (100%). In addition, Hp was strongly implicated in the occurrence of gastric ulcers, accounting for more than 80% of ulcers.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Helicobacter pylori occur at a frequency of 91% in the Brazzaville population. This study also showed that certain epidemiological factors such as the patients’ lifestyle, including promiscuity, tap water consumption, and the use of latrines and sanitary facilities were associated with the occurrence of Hp infection. Epigastric pain, dyspeptic disorders and digestive bleeding were the symptoms experienced by Hp-infected patients. Although the mucosa was normal in most cases, the lesions identified were ulcers, gastritis, and ulcerative and frosted lesions. The search for Hp should be routine in cases of suspected Hp infection, and improve the management of Hp-infected patients.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Atipo-Ibara, B.H., Boumba, A., Atipo Ibara Ollandzobo Ikobo, L.C., Mongo-Onkouo, A., Mimiesse Monamou, J.F., Itoua-Ngaporo, N.A., Moukassa, D., Atipo Ibara, B.I. and Ibara J.-R. (2023) Helicobacter Pylori Infection: Epidemiological, Clinical and Endoscopic Aspects in Brazzaville. Open Journal of Gastroenterology, 13, 131-139. https://doi.org/10.4236/ojgas.2023.134014</p></sec></body><back><ref-list><title>References</title><ref id="scirp.124243-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Bommelaer, G. and Stef, A. (2009) Peptic Ulcer Disease: Before and after Helicobacter pylori. Clinical Gastroenterology and Biology, 33, 626-634. https://doi.org/10.1016/j.gcb.2009.07.004</mixed-citation></ref><ref id="scirp.124243-ref2"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Korwin</surname><given-names> J.D. </given-names></name>,<etal>et al</etal>. (<year>2014</year>)<article-title>Epidemiology of Helicobacter pylori Infection and Gastric Cancer</article-title><source> Revue du Praticien</source><volume> 64</volume>,<fpage> 189</fpage>-<lpage>193</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.124243-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hunt, R.H., Xiao, S.D. and Megraud, F. (2011) Helicobacter pylori in Developing Countries. World Gastroenterology Organisation Global Guideline. Journal of Gastrointestinal and Liver Diseases, 20, 299-304.</mixed-citation></ref><ref id="scirp.124243-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organisation (1994) IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Geneva, Vol. 61, 177-240.</mixed-citation></ref><ref id="scirp.124243-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Malgalhaes, D.M. and Luzza, F. (2006) Epidemiology of Helicobacter pylori Infection. Helicobacter, 11, 1-5. https://doi.org/10.1111/j.1478-405X.2006.00429.x</mixed-citation></ref><ref id="scirp.124243-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Suerbaum, S. and Michetti, P. (2002) Helicobacter pylori Infection. The New England Journal of Medicine, 347, 1175-1186. https://doi.org/10.1056/NEJMra020542</mixed-citation></ref><ref id="scirp.124243-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">De Korwin, J.D. and Lozzniewski, A. (2000) Helicobacter pylori: Basic Concepts and Perspectives. EMC-Gastroenterology, 1-16.</mixed-citation></ref><ref id="scirp.124243-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Aguemon, B.D., Struelens, M.J., Massougbodji, A. and Ouendo, E.M. (2005) Prevalence and Risk-Factors for Helicobacter pylori Infection in Urban and Rural Beninese Populations. Clinical Microbiology and Infection, 11, 611-617. https://doi.org/10.1111/j.1469-0691.2005.01189.x</mixed-citation></ref><ref id="scirp.124243-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ankouane Andoulo, F., Noah Noah, D., Tagni-Sartre, M., Ndjitoyap Ndam, E.C. and Ngu Blackett, K. (2013) Epidemiology of Helicobacter pylori Infection in Yaoundé: From Peculiarity to African Enigma. Pan African Medical Journal, 16, 115-120. https://doi.org/10.11604/pamj.2013.16.115.3007</mixed-citation></ref><ref id="scirp.124243-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Werme, K., Bisseye, C., Ouedraogo, I., Yonli, A.T., Ouermi, D., Djigma, F., et al. (2015) Molecular Diagnosis of Helicobacter pylori by PCR in Patients Undergoing Gastroenterology Consultation at the Saint Camille Medical Centre in Ouagadougou. Pan African Medical Journal, 21, 123-128. https://doi.org/10.11604/pamj.2015.21.123.6001</mixed-citation></ref><ref id="scirp.124243-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Guantai M’itonga, L., Nyerere Kimanga, A., Wangari Ngugi, C. and Mutie, T.M. (2015) Association of Helicobacter pylori VacA Gene Polymorphisms and CagA Gene with Clinical Outcome in Dyspeptic Patients in Kenya. International Journal of Medical and Health Sciences, 5, 436-444.</mixed-citation></ref><ref id="scirp.124243-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Ibara, J.R., Mbou, V.A., Gatsele-Yala, C., Ngoma-Mambouana, P., Ngounga, B. and Yala, F. (2005) Helicobacter pylori Infection in Children Aged 6 Months to 16 Years in Brazzaville, Congo. Gastroentérologie Clinique et Biologique, 29, 752-753. https://doi.org/10.1016/S0399-8320(05)82170-0</mixed-citation></ref><ref id="scirp.124243-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ontsira Ngoyi, E.N., Atipo Ibara, B.I., Moyen, R., Ahoui Apendi, P.C., Ibara, J.R., Obengui, O., et al. (2015) Molecular Detection of Helicobacter pylori and Its Antimicrobial Resistance in Brazzaville, Congo. Helicobacter, 20, 316-320. https://doi.org/10.1111/hel.12204</mixed-citation></ref><ref id="scirp.124243-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Itoua-Ngaporo, N.A., Mimiesse Monamou, J.F., Ahoui Apendi, C., Mongo Onkouo, A., Atipo Ibara ollandzobo, L.C., et al. (2018) Epidemiological, Clinical and Endoscopic Profil of Helicobacter pylori in Two Digestive Endoscopy Centers in Brazzaville. Gastroenterology, Hepatology &amp; Digestive Disorders, 1, 1-5. https://doi.org/10.33425/2639-9334.1025</mixed-citation></ref><ref id="scirp.124243-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ontsira Ngoyi, E.N., Guilloteau, C., Benejat, L., Mongo Onkouo, A., Buissonnière, A., Aloumba, A., et al. (2019) CagA and VacA Helicobacter pylori Pathogenicity Factors in Brazzaville, Congo. Open Journal of Medical Microbiology, 9, 186-200. https://doi.org/10.4236/ojmm.2019.94018</mixed-citation></ref><ref id="scirp.124243-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Zamani, M., Vahedi, A., Maghdouri, Z.S. and Hokri-Shirvani, J. (2017) Role of Food in Environmental Transmission of Helicobacter pylori. Caspian Journal of Internal Medicine, 8, 146-152.</mixed-citation></ref><ref id="scirp.124243-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Khalifa, M.M., Sharaf, R.R. and Aziz, R.K. (2010) Helicobacter pylori: A Poor Man’s Gut Pathogen? Gut Pathogens, 2, 1-12. https://doi.org/10.1186/1757-4749-2-2</mixed-citation></ref><ref id="scirp.124243-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Bommelaer, G., Des varannes, S.B., Fléjou, J.F., Matysiak, T., Poynard, T., Richard, A., et al. (2001) CagA Status and Virulence of Helicobacter pylori Strains. Results of a French Multicentric Prospective Study. Gastroentérologie Clinique et Biologique, 25, 1084-1089.</mixed-citation></ref><ref id="scirp.124243-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Attaf, N., Cherkaoui, N., Choulli, M.K., Ghazali, A., Mokhtari, A. and Soulaymani, A. (2004) Epidemiological Profile of Helicobacter pylori Infection in the Gharb-Chrarda-Beni Hssen Region. Biology and Health, 4, 25-34.</mixed-citation></ref><ref id="scirp.124243-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Bouh, K.O., Jidou, M.T. and El Bara, A. (2015) Seroprevalence of Helicobacter Pylori Infection in an Asymptomatic Mauritanian Population. African Journal of Hepato-Gastroenterology, 9, 18-21. https://doi.org/10.1007/s12157-014-0576-6</mixed-citation></ref><ref id="scirp.124243-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ilboudo, D., Sangare, L., Sanou, J., Bougouma, A. and Diomande, I. (1997) Epidemiological and Clinical Aspects of Helicobacter pylori Infection in Tropical Areas. Médecine d’Afrique Noire, 44, 24-28.</mixed-citation></ref><ref id="scirp.124243-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Zhu, Y., Zhou, X., Wu, J., Su, J. and Zhang, G. (2014) Risk Factors and Prevalence of Helicobacter pylori in Persistent High Incidence Area of Gastric Carcinoma in Yangzhong City. Gastroenterology Research and Practice, 2014, Article ID: 481365. https://doi.org/10.1155/2014/481365</mixed-citation></ref></ref-list></back></article>